Quidel Rapid Antigen Test for COVID-19 Wins Authorization

Quidel Rapid Antigen Test for COVID-19 Wins Authorization

Source: 
Motley Fool
snippet: 

Diagnostic healthcare specialist Quidel (NASDAQ:QDEL) today announced it has received Emergency Use Authorization from the Food and Drug Administration for a rapid COVID-19 antigen test that returns results without the use of a test instrument. Shares were soaring 8% today on the news.